Analysts recognize anticoagulation operator that stifles SARS-CoV-2 replication in vitro Kumar Jeetendra | July 27, 2020 Effective antivirals with secure clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients using COVID-19, the authors discovered that hypercoagulability according to elevated levels of D-dimers was associated with illness severity. By calculating of a U.S. FDA approved drug library, the authors identified …
Parkinson’s disease is a free danger factor for biting the dust from COVID-19, study recommends Kumar Jeetendra | October 3, 2020 A fresh study of about 80,000 patients shows that people with Parkinson’s disease (PD) have a 30% greater risk of dying from COVID-19 than individuals without the neurodegenerative condition. The new analysis conducted by researchers at University of Iowa Health Care based on patient information in the TriNetX COVID-19 research network suggests that Parkinson’s disease …
Study affirms most basic complexities related with COVID-19 Kumar Jeetendra | December 8, 2020 A large study of patients in america who contracted coronavirus disease 2019 (COVID-19) confirms many complications of the disease, according to new research in CMAJ (Canadian Medical Association Journal). Understanding the full range of associated conditions can aid in prognosis, guide treatment decisions and better inform patients as to their actual risks for the variety …
Researchers give knowledge on how lung microorganisms secure against attacking microbes Kumar Jeetendra | December 9, 2020 New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following …
Researchers pick out new weapon to war the growing tide of antibiotic-resistant bacteria Kumar Jeetendra | December 24, 2020 As scientists around the globe wage war against a publication, deadly virus, one University of Colorado Boulder laboratory is working on new weapons to battle a distinct microbial threat: a rising tide of antibiotic-resistant bacteria which, if left unattended, could kill an estimated 10 million people annually by 2050. In a paper published Friday in …
Sustainable immune dysregulation because of COVID-19 in non-hospitalized patients Kumar Jeetendra | December 31, 2020 COVID-19, which has killed 1.7 million people globally, doesn’t follow a uniform path. Others, especially those with comorbidities, can create severe clinical disease with atypical pneumonia and multiple system organ failure. Since the first cases were reported in December 2019, the SARS-CoV-2 virus that causes COVID-19 has surged into a pandemic, with cases and deaths …
Study uncovers immune defense system that shields the lungs from viral diseases Kumar Jeetendra | March 18, 2021 Scientists have discovered a previously unknown arm of the immune defense system that protects the lung from lethal viral infections. Respiratory diseases caused by viruses such as influenza A and SARS-CoV-2 cause harm not only through their own activities, but also from collateral damage as the immune system reacts to combat the infection. A timely …
